This is to inform you that Everlight Chemical Industrial Corporation has received the Establishment Inspection Report (EIR) from the U.S. FDA for the Voluntary Action Indicated (VAI) at API manufacturing facility in Taoyuan City, Taiwan, R.O.C. The inspection was conducted between Oct 14 and Oct 18, 2019.

The receipt of the Establishment Inspection Report (EIR) indicates a successful closure of the inspection. This is an endorsement of our commitment to global standards of Quality and Compliance. We are  expected to enable filing of letter of authorization applications with our clients in several global markets. We stay committed to enable affordable access to better chemistry better life.